Estuardo Aguilar-Cordova
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$1.6MFederal grants as PI4 awards
0Patents grantedNone matched
136Papers6,203 citations
Federal awards and patents by year
AwardsPatents
4 awards · $1.6M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Mar 3, 2021 | NIH | SBIR Phase II Immuno-Oncology for Pancreatic Cancer: A Combination Clinical Trial with Chemotherapy and Radiation | $611K | ADVANTAGENE, INC |
| Jan 31, 2020 | NIH | SBIR Phase II Immuno-Oncology for Pancreatic Cancer: A Combination Clinical Trial with Chemotherapy and Radiation | $611K | ADVANTAGENE, INC |
| Sep 13, 2019 | NIH | SBIR Phase II Immuno-Oncology for Pancreatic Cancer: A Combination Clinical Trial with Chemotherapy and Radiation | $116K | ADVANTAGENE, INC |
| Dec 23, 2015 | NIH | SBIR Phase II Immuno-Oncology for Pancreatic Cancer: A Combination Clinical Trial with Chemotherapy and Radiation | $300K | ADVANTAGENE, INC |
1 patents as inventor
- US ADVANTAGENE, INC—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#1,282
Awards as PI#566
Patents#273
Companies
- ADVANTAGENE, INCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.